Findings showed patients treated with efgartigimod alfa–hyaluronidase achieved a statistically significant improvement in MGII PRO ocular scores vs placebo at week 4. Topline data were announced from ...
The American Journal of Managed Care: Daratumumab and Hyaluronidase-fihj–Based Quadruplet Regimen Approved in MM
Daratumumab/hyaluronidase-fihj plus bortezomib, lenalidomide, and dexamethasone is now approved by the FDA to treat newly diagnosed multiple myeloma (MM) in patients ...
The American Journal of Managed Care: FDA Approves Efgartigimod Alfa and Hyaluronidase for CIDP
The FDA today approved efgartigimod alfa and hyaluronidase-qvfc for the treatment of adult patients with chronic inflammatory demyelinating polyneuropathy (CIDP). "This medication has a novel ...
The SC formulation of efgartigimod alfa plus hyaluronidase-qvfc is currently marketed under the trade name Vyvgart Hytrulo and is approved for the treatment of generalized myasthenia gravis. The Food ...
Digital Journal: The revolution of hyaluronidase: Charting Dr. Patrick Treacy’s contribution to aesthetic medicine
The revolution of hyaluronidase: Charting Dr. Patrick Treacy’s contribution to aesthetic medicine
Findings reveal fermentation transforms food proteins into microbial proteins, highlighting their role in nutrition, gut microbiome interactions, and potential health benefits.
An AI-assisted analysis of the gut microbiome in colorectal cancer cases revealed substantial differences between early- and late-onset disease, including microbial diversity and associations with ...
Can the infant gut microbiome recover after C-section? New research explores early microbial patterns, sibling exposure, and asthma outcomes.
The gut microbiome shapes immune and nerve signaling across aging, even as memory decline often accelerates after 80. Studies of centenarians show distinct microbial profiles, and animal experiments ...